Menu +

BioNTech – Supporting innovative medical technology to fight COVID-19

Supporting innovative medical technology is key to Team Europe’s response to the Coronavirus pandemic: this is why the European Investment Bank, together with the European Commission, is backing German biopharmaceutical company BioNTech’s COVID-19 vaccine development and manufacturing programme with up to €100 million in debt financing under the Investment Plan for Europe.

Find out more on our support to BioNTech’s COVID-19 vaccine development programme

https://www.eib.org/de/press/all/2020-144-eib-to-provide-biontech-with-up-to-eur-100-million-in-debt-financing-for-covid-19-vaccine-development-and-manufacturing.htm

  • EIB –